sRNAlytics is at the forefront of small RNA research. They offer technology and services to facilitate drug discovery and development by providing deep analysis of disease pathways. Their artificial intelligence-based discovery platform called sRNA-FIND uncovers drug targets and translatable biomarkers. Their laboratory protocols combined with sRNA-FIND and a growing database of over 15,000 patient samples is focused on accelerating their partners’ drug programs.